AstraZeneca To Buy Rare-Disease Specialist Drugmaker Alexion For $39 Billion

AstraZeneca plc has announced it will buy Alexion Pharmaceuticals, Inc. for $39 billion. AstraZeneca and Alexion said this morning that their boards unanimously approved the deal. It is expected to close in the third quarter of 2021.